• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

男性英国地区心脏研究中的血液学变量与未来静脉血栓栓塞风险。联合 D-二聚体和 APTT 作为血栓栓塞的预测性试验?

Haematological variables and risk of future venous thromboembolism in the British Regional Heart Study on men. Combined D-dimer and APTT as a predictive test for thromboembolism?

机构信息

Department of Primary Care and Population Health, UCL, Royal Free Campus, London, UK.

Population Health Research Institute, St George's, University of London, London, UK.

出版信息

Br J Haematol. 2022 Aug;198(3):587-594. doi: 10.1111/bjh.18288. Epub 2022 Jun 2.

DOI:10.1111/bjh.18288
PMID:35655415
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9543457/
Abstract

We examined the associations between haematological and inflammatory variables with future venous thromboembolism (VTE), in 3494 men aged 60-79 years, with no previous history of VTE or myocardial infarction, who were not receiving oral anticoagulants. After a mean follow-up period of 18 years, there were 149 confirmed cases of fatal or non-fatal VTE (deep vein thrombosis and/or pulmonary embolism). Among classical cardiovascular risk factors, only obesity and cigarette smoking were associated with VTE risk. After adjustment for age, obesity and smoking, VTE risk was associated with coagulation factor VIII, factor IX, von Willebrand factor (VWF), activated partial thromboplastin time (APTT), and fibrin D-dimer. Hazard ratios (95% CI) for top to bottom quarters (bottom to top for APTT), were respectively 2.17 (1.37, 3.44), 2.15 (1.30, 3.53), 2.02 (1.27, 3.22), 2.43 (1.47, 4.02) and 3.62 (2.18, 6.08). The 11% of men with both the shortest APTT and highest D-dimer combined had a 5.02 (2.37, 10.62) higher risk of VTE. VTE risk was not associated with fibrinogen, factor VII or activated protein C resistance; full blood count variables or with inflammatory markers, plasma viscosity, C-reactive protein or interleukin-6. The combination of D-dimer and APTT merits evaluation as an adjunct to VTE risk prediction scores.

摘要

我们研究了 3494 名年龄在 60-79 岁、无静脉血栓栓塞(VTE)或心肌梗死既往史且未服用口服抗凝剂的男性的血液学和炎症变量与未来静脉血栓栓塞(VTE)之间的关联。在平均 18 年的随访后,有 149 例确诊的致命或非致命 VTE(深静脉血栓形成和/或肺栓塞)病例。在经典心血管危险因素中,只有肥胖和吸烟与 VTE 风险相关。在调整年龄、肥胖和吸烟因素后,VTE 风险与凝血因子 VIII、IX、血管性血友病因子(VWF)、活化部分凝血活酶时间(APTT)和纤维蛋白 D-二聚体相关。最高四分位到最低四分位(APTT 相反)的危险比(95%CI)分别为 2.17(1.37,3.44)、2.15(1.30,3.53)、2.02(1.27,3.22)、2.43(1.47,4.02)和 3.62(2.18,6.08)。APTT 最短和 D-二聚体最高的男性占 11%,其 VTE 风险增加 5.02(2.37,10.62)。VTE 风险与纤维蛋白原、因子 VII 或活化蛋白 C 抵抗无关;全血计数变量或与炎症标志物、血浆黏度、C 反应蛋白或白细胞介素-6 无关。D-二聚体和 APTT 的组合作为 VTE 风险预测评分的辅助手段值得进一步评估。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1783/9543457/dd8f57fea167/BJH-198-587-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1783/9543457/dd8f57fea167/BJH-198-587-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1783/9543457/dd8f57fea167/BJH-198-587-g001.jpg

相似文献

1
Haematological variables and risk of future venous thromboembolism in the British Regional Heart Study on men. Combined D-dimer and APTT as a predictive test for thromboembolism?男性英国地区心脏研究中的血液学变量与未来静脉血栓栓塞风险。联合 D-二聚体和 APTT 作为血栓栓塞的预测性试验?
Br J Haematol. 2022 Aug;198(3):587-594. doi: 10.1111/bjh.18288. Epub 2022 Jun 2.
2
The clinical significance of a shortened activated partial thromboplastin time in patients with connective tissue disease.结缔组织病患者活化部分凝血活酶时间缩短的临床意义。
Clin Rheumatol. 2021 Nov;40(11):4675-4683. doi: 10.1007/s10067-021-05781-w. Epub 2021 Jun 16.
3
Biomarkers for the prediction of venous thromboembolism in critically ill COVID-19 patients.用于预测危重症 COVID-19 患者静脉血栓栓塞症的生物标志物。
Thromb Res. 2020 Dec;196:308-312. doi: 10.1016/j.thromres.2020.09.017. Epub 2020 Sep 15.
4
[Estimation of venous thromboembolism risk with thrombotic biomarkers in cancer patients].[利用血栓形成生物标志物评估癌症患者静脉血栓栓塞风险]
Zhonghua Zhong Liu Za Zhi. 2015 Apr;37(4):283-9.
5
Long-term risk of recurrence in patients with a first unprovoked venous thromboembolism managed according to d-dimer results; A cohort study.根据 D-二聚体检测结果管理的首次无诱因静脉血栓栓塞症患者的长期复发风险:一项队列研究。
J Thromb Haemost. 2019 Jul;17(7):1144-1152. doi: 10.1111/jth.14458. Epub 2019 May 20.
6
Fibrin monomer complex as a potential thrombosis marker related to venous thromboembolism risk in pregnant women.纤维蛋白单体复合物作为一种潜在的血栓标志物,与孕妇静脉血栓栓塞风险相关。
Ann Clin Biochem. 2023 Jul;60(4):279-285. doi: 10.1177/00045632231160667. Epub 2023 Mar 7.
7
Peak thrombin generation and subsequent venous thromboembolism: the Longitudinal Investigation of Thromboembolism Etiology (LITE) study.峰值凝血酶生成与随后的静脉血栓栓塞:血栓形成病因的纵向研究(LITE 研究)。
J Thromb Haemost. 2009 Oct;7(10):1639-48. doi: 10.1111/j.1538-7836.2009.03561.x. Epub 2009 Jul 28.
8
Mechanisms and mitigating factors for venous thromboembolism in chronic kidney disease: the REGARDS study.慢性肾脏病静脉血栓栓塞症的发病机制及影响因素:REGARDS 研究。
J Thromb Haemost. 2018 Sep;16(9):1743-1752. doi: 10.1111/jth.14235. Epub 2018 Aug 9.
9
Venous thrombosis, thromboembolism, biomarkers of inflammation, and coagulation in coronavirus disease 2019.2019冠状病毒病中的静脉血栓形成、血栓栓塞、炎症生物标志物及凝血
J Vasc Surg Venous Lymphat Disord. 2021 Jul;9(4):835-844.e4. doi: 10.1016/j.jvsv.2020.11.006. Epub 2020 Nov 12.
10
D-dimer at venous thrombosis diagnosis is associated with risk of recurrence.D-二聚体在静脉血栓诊断中与复发风险相关。
J Thromb Haemost. 2017 May;15(5):917-924. doi: 10.1111/jth.13648. Epub 2017 Feb 24.

引用本文的文献

1
Analysis of risk factors and prediction model construction of deep vein thrombosis in patients with lumbar degenerative diseases before surgery.腰椎退变性疾病患者术前深静脉血栓形成的危险因素分析及预测模型构建
Sci Rep. 2025 Jul 18;15(1):26069. doi: 10.1038/s41598-025-10752-1.
2
Correlation Between Blood Coagulation Profile and Viscosity: Clinical Laboratory Observational Study.凝血指标与粘度之间的相关性:临床实验室观察性研究。
Med Sci (Basel). 2025 Feb 16;13(1):20. doi: 10.3390/medsci13010020.
3
Cohort study of prediction of venous thromboembolism in emergency department patients with extremity symptoms.

本文引用的文献

1
Exploring Opportunities for Primary Prevention of Unprovoked Venous Thromboembolism: Ready for Prime Time?探索未诱发静脉血栓栓塞症一级预防的机会:是否已准备就绪?
J Am Heart Assoc. 2020 Dec;9(23):e019395. doi: 10.1161/JAHA.120.019395. Epub 2020 Nov 16.
2
Cardiovascular Risk Factors Associated With Venous Thromboembolism.心血管危险因素与静脉血栓栓塞症。
JAMA Cardiol. 2019 Feb 1;4(2):163-173. doi: 10.1001/jamacardio.2018.4537.
3
High levels of coagulation factors and venous thrombosis risk: strongest association for factor VIII and von Willebrand factor.
急诊科有肢体症状患者静脉血栓栓塞预测的队列研究。
Intern Emerg Med. 2025 Apr;20(3):865-875. doi: 10.1007/s11739-024-03696-3. Epub 2024 Jul 2.
4
Plasma levels of coagulation factors VIII and IX and risk of venous thromboembolism: Systematic review and meta-analysis.血浆凝血因子 VIII 和 IX 水平与静脉血栓栓塞风险:系统评价和荟萃分析。
Thromb Res. 2023 Sep;229:31-39. doi: 10.1016/j.thromres.2023.06.026. Epub 2023 Jun 28.
高凝因子水平与静脉血栓风险:VIII 因子和血管性血友病因子相关性最强。
J Thromb Haemost. 2019 Jan;17(1):99-109. doi: 10.1111/jth.14343. Epub 2018 Dec 18.
4
Association of Traditional Cardiovascular Risk Factors With Venous Thromboembolism: An Individual Participant Data Meta-Analysis of Prospective Studies.传统心血管危险因素与静脉血栓栓塞的关联:前瞻性研究的个体参与者数据荟萃分析
Circulation. 2017 Jan 3;135(1):7-16. doi: 10.1161/CIRCULATIONAHA.116.024507. Epub 2016 Nov 9.
5
Deep vein thrombosis and pulmonary embolism.深静脉血栓形成和肺栓塞。
Lancet. 2016 Dec 17;388(10063):3060-3073. doi: 10.1016/S0140-6736(16)30514-1. Epub 2016 Jun 30.
6
Prospective study of plasma D-dimer and incident venous thromboembolism: The Atherosclerosis Risk in Communities (ARIC) Study.血浆D-二聚体与静脉血栓栓塞事件的前瞻性研究:社区动脉粥样硬化风险(ARIC)研究
Thromb Res. 2015 Oct;136(4):781-5. doi: 10.1016/j.thromres.2015.08.013. Epub 2015 Aug 28.
7
Cohort Profile Update: The British Regional Heart Study 1978-2014: 35 years follow-up of cardiovascular disease and ageing.队列研究概况更新:英国地区心脏研究(1978 - 2014年):心血管疾病与衰老的35年随访
Int J Epidemiol. 2015 Jun;44(3):826-826g. doi: 10.1093/ije/dyv141.
8
Inflammatory plasma markers and risk for venous thromboembolism.炎症血浆标志物与静脉血栓栓塞风险
J Thromb Thrombolysis. 2014;38(2):190-5. doi: 10.1007/s11239-013-1033-6.
9
Epidemiology of venous thromboembolism: the need for large (including prospective) studies and meta-analyses.静脉血栓栓塞症的流行病学:开展大型(包括前瞻性)研究和荟萃分析的必要性。
J Thromb Haemost. 2012 Oct;10(10):2186-8. doi: 10.1111/j.1538-7836.2012.04882.x.
10
Fibrin D-dimer, tissue-type plasminogen activator, von Willebrand factor, and risk of incident stroke in older men.纤维蛋白原 D-二聚体、组织型纤溶酶原激活物、血管性血友病因子与老年男性首发脑卒中风险的关系。
Stroke. 2012 May;43(5):1206-11. doi: 10.1161/STROKEAHA.111.636373. Epub 2012 Mar 1.